BIOMX INC (PHGE) Stock Price, Quote, News and Overview
NYSEARCA:PHGE - NYSE Arca - US09090D3017 - Common Stock - Currency: USD
PHGE Quote, Performance and Key Statistics
0.5459
+0.01 (+1.15%)
The current stock price of PHGE is 0.5459 USD. In the past month the price decreased by -14.97%. In the past year, price decreased by -84.4%.
PHGE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.81 | 301.01B | ||
| AMGN | AMGEN INC | 13.81 | 147.14B | ||
| GILD | GILEAD SCIENCES INC | 22.63 | 130.06B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1646.62 | 122.76B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.3 | 61.38B | ||
| ARGX | ARGENX SE - ADR | 320.27 | 36.37B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 30.28B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.70B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.47B | ||
| NTRA | NATERA INC | N/A | 19.23B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 18.60B | ||
| BIIB | BIOGEN INC | 7.07 | 17.05B |
Related stock screener links
About PHGE
Company Profile
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. The firm is focused on developing both natural and engineered phage therapies. The company develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The firm discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
Company Info
BIOMX INC
22 Einstein St., Floor 4
Ness Ziona MARYLAND 7414002 IL
CEO: Jonathan Solomon
Employees: 65
Company Website: https://www.biomx.com/
Investor Relations: http://ir.biomx.com/
Phone: 972723942377
BIOMX INC / PHGE FAQ
What is the stock price of BIOMX INC today?
The current stock price of PHGE is 0.5459 USD. The price increased by 1.15% in the last trading session.
What is the ticker symbol for BIOMX INC stock?
The exchange symbol of BIOMX INC is PHGE and it is listed on the NYSE Arca exchange.
On which exchange is PHGE stock listed?
PHGE stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for BIOMX INC stock?
8 analysts have analysed PHGE and the average price target is 7.14 USD. This implies a price increase of 1207.93% is expected in the next year compared to the current price of 0.5459. Check the BIOMX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIOMX INC worth?
BIOMX INC (PHGE) has a market capitalization of 13.63M USD. This makes PHGE a Nano Cap stock.
How many employees does BIOMX INC have?
BIOMX INC (PHGE) currently has 65 employees.
What are the support and resistance levels for BIOMX INC (PHGE) stock?
BIOMX INC (PHGE) has a support level at 0.54 and a resistance level at 0.56. Check the full technical report for a detailed analysis of PHGE support and resistance levels.
Should I buy BIOMX INC (PHGE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PHGE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PHGE, evaluating the profitability, health, valuation and growth aspects
- BIOMX INC (PHGE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOMX INC (PHGE) Sales and EPS estimates to see what analysts future expectations are.
- BIOMX INC (PHGE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOMX INC (PHGE) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOMX INC (PHGE) Stock Chart to make your own analysis
- BIOMX INC (PHGE) Latest news and press-releases to stay up to date.
Does BIOMX INC (PHGE) stock pay dividends?
PHGE does not pay a dividend.
When does BIOMX INC (PHGE) report earnings?
BIOMX INC (PHGE) will report earnings on 2025-05-19, before the market open.
What is the Price/Earnings (PE) ratio of BIOMX INC (PHGE)?
BIOMX INC (PHGE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.3).
What is the Short Interest ratio of BIOMX INC (PHGE) stock?
The outstanding short interest for BIOMX INC (PHGE) is 0.17% of its float. Check the ownership tab for more information on the PHGE short interest.
PHGE Technical Analysis
PHGE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PHGE. While PHGE seems to be doing ok healthwise, there are quite some concerns on its profitability.
PHGE Financial Highlights
Over the last trailing twelve months PHGE reported a non-GAAP Earnings per Share(EPS) of -5.3. The EPS increased by 43.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -41% | ||
| ROE | -73.41% | ||
| Debt/Equity | 0 |
PHGE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to PHGE. The Buy consensus is the average rating of analysts ratings from 8 analysts.